UF Health Research To Create Cancer Vaccine Gets $2.5M in New Funding
The Pediatric Cancer Foundation’s Cure-Search for Children’s Cancer is funding UF’s Dr. Elias Sayour’s efforts to create a novel vaccine to treat brain cancer in children.
UF Health Study Suggests Association Between COVID-19 and Erectile Dysfunction
If the threat of death or severe disability isn’t enough to convince someone to get a COVID-19 vaccination, men can add this possible consequence of coronavirus infection — erectile dysfunction.
Jaw-Dropping Recovery: UF Veterinarians Save Injured Dairy Calf Using Creative 3D Solution
Thanks to a creative solution devised by University of Florida veterinarians using 3D printing technology, a newborn calf that sustained a broken lower jaw soon after birth at the UF dairy farm in Hague has fully recovered and is now an 11-month-old growing heifer in the herd.
Oragenics Announces Positive COVID-19 Challenge Study Results Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
UF startup and Sid Martin Biotech alumni company Oragenics, Inc. announced the results from its study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study. The study provided preclinical data for formulations designed for both intranasal and intramuscular administration.
Taking Cancer Research Out of the Culture Dish and Into 3-Dimensions
After decades of research, cancer is still the leading cause of death in the United States. Up to this point, cancer study has remained almost exclusively within the 2D bounds of traditional cell culture plates. Dr. Gregory Sawyer, professor and distinguished teaching scholar in the Department of Mechanical and Aerospace Engineering, is revolutionizing cancer research.
Skip the Line for Safer Voting, Vaccinations, or Other Activities with inLine Ticketing
One socially-minded researcher at UF decided to do something to keep poll workers and voters safer while casting their ballots. Dr. Juan Gilbert, The Banks Family Preeminence Endowed Professor and chair of the UF Department of Computer & Information Science & Engineering (CISE), saw the potential danger of standing in line to vote during the election and was inspired to create the inLine Ticketing system.
Clinical Challenges: Gene Therapy for Inherited Retinal Diseases
The FDA approval of UF’s AAV technology in voretigene neparvovec (Luxturna) for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy almost 4 years ago marked a turning point in gene therapy.
Acquisition of UF Faculty Startup AbFero Provides Iron Chelators for Numerous Diseases
Late last week, Danish biotech Pharmacosmos announced it had acquired AbFero Pharmaceuticals, a University of Florida startup, for $225 million. AbFero is developing compounds called iron chelators created in Dr. Raymond Bergeron’s lab at UF. Chelators remove extra iron from the body.
Pharmacosmos Group Acquires AbFero Pharmaceuticals, Inc.
Pharmacosmos Group, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, today announced the acquisition of UF startup AbFero Pharmaceuticals, Inc., a Boston-based, privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload.
Too Much Iron? Pharmacosmos Is Betting $225M on a New Potential Solution for That
Pharmacosmos is putting down $225 million to purchase AbFero, a spinout from Raymond Bergeron’s lab at the University of Florida. Its lead candidate, SP-420, recently completed Phase I safety studies as a treatment for transfusional iron overload.